fingolimod hydrochloride has been researched along with Abortion, Spontaneous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Liu, Y; Wang, J; Xiong, M; Xu, L; Zhou, F; Zhu, J | 1 |
| Cohen, JA; Collins, W; Francis, G; Heining, P; Kappos, L; Karlsson, G; Koren, G; Zhang, X | 1 |
| Aguilera, C; Tintoré, M; Tur, C | 1 |
3 other study(ies) available for fingolimod hydrochloride and Abortion, Spontaneous
| Article | Year |
|---|---|
The experimental research of pregnancy immune tolerance induced by FTY720 via blocking S1P signal transduction pathway.
Topics: Abortion, Spontaneous; Animals; Decidua; Dendritic Cells; Female; Fingolimod Hydrochloride; Humans; Immune Tolerance; Lentivirus; Mice; Mice, Inbred BALB C; Pregnancy; RNA, Small Interfering; Signal Transduction; Sphingosine-1-Phosphate Receptors | 2019 |
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Propylene Glycols; Sphingosine | 2014 |
[Disease modifying drugs in multiple sclerosis and pregnancy].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Antibodies, Monoclonal, Humanized; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunologic Factors; Immunosuppressive Agents; Infant, Newborn; Interferon-beta; Multiple Sclerosis; Natalizumab; Peptides; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Propylene Glycols; Sphingosine; Stillbirth | 2012 |